Immunization with Lentivirus-Like Particles Elicits a Potent SIV-Specific Recall Cytotoxic T-Lymphocyte Response in Rhesus Monkeys
- 1 February 1993
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 9 (2) , 129-132
- https://doi.org/10.1089/aid.1993.9.129
Abstract
An effective acquired immunodeficiency syndrome (AIDS) vaccine should be capable of eliciting human immunodeficiency virus (HlV)-specific cytotoxic T-lymphocyte (CTL) responses. We have explored the use of lentivirus-like particles produced in mammalian cells infected with a recombinant vaccinia virus to immunize for the induction of CTL in the simian immunodeficiency virus (SIV)/rhesus monkey model for AIDS. SIV-like particles in a threonyl-MDP-based adjuvant did not elicit a high frequency of SIV gag-specific effector cells in naive rhesus monkeys. However, immunization with these particles elicited a potent recall CTL response in monkeys previously vaccinated with a recombinant vaccinia-SIV virus. These observations suggest that poxvirus-produced virus-like particles may represent a safe immunogen for use in periodic boosting to maintain viable cell-mediated immunity to the AIDS virus.Keywords
This publication has 17 references indexed in Scilit:
- Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160Science, 1992
- Formation of Lentivirus Particles by Mammalian Cells Infected with Recombinant Fowlpox VirusAIDS Research and Human Retroviruses, 1991
- Neutralizing Antibodies Against HIV-1 BRU and SF2 Isolates Generated in Mice Immunized with Recombinant Vaccinia Virus Expressing HIV-1 (BRU) Envelope Glycoproteins and Boosted with Homologous gp160AIDS Research and Human Retroviruses, 1991
- Recombinant Virus Vaccine-Induced SIV-specific CD8 + Cytotoxic T LymphocytesScience, 1991
- Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoproteinThe Lancet, 1991
- Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIVVirology, 1990
- Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.Proceedings of the National Academy of Sciences, 1989
- Structure of the human class I histocompatibility antigen, HLA-A2Nature, 1987
- Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency virusesNature, 1987
- The Epidemiology of AIDS: Current Status and Future ProspectsScience, 1985